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Objective: No method of measuring technical performance exists for the stage I Nor-
wood procedure. Hospital mortality is usually used as a surrogate for technical perfor-
mance, but evidence is lacking to support this concept. A technical score was designed
by expert consensus.
Methods: The technical score included the following steps: (1) Stage Iwas divided into
subprocedures according to anatomic areaswhere an intervention is performed. (2) For
each subprocedure, three score categories (optimal, adequate, and inadequate) were
defined on the basis of echocardiography, catheterization, and/or clinical data. (3) Sub-
procedures were analyzed for the whole group and by surgeon. (4) Overall repair was
also scored: optimal if all attempted subprocedureswere optimal, inadequate if anywas
inadequate, and adequate for everything in between. (5) All patients undergoing the
stage I procedure from January 2004 to December 2006 were retrospectively studied.
Results: One hundred ten patients were included (operated on by six surgeons), and 4
were excluded for lack of reliable postoperative data. Most subprocedures were
scored as optimal. Subprocedures with the largest inadequate scores were distal
arch reconstruction in 7 (6%) patients and aortopulmonary shunt in 3 (5%). No statis-
tical differences were found among surgeons either by subprocedure or by overall out-
come, although individual sample sizes were small. The overall score correlated with
length of stay, extracorporeal membrane oxygenator support, and hospital mortality.
Conclusions: Technical performance can be measured after the stage I procedure, and
performance score correlates with early outcome. This score may also be useful as
a self-assessment tool.
T
he stage I Norwood surgical palliation (stage I) is currently the standard of
treatment for neonates with hypoplastic left heart syndrome and related mal-
formations. Although constant improvements in early diagnosis, characteriza-
tion of risk factors, and treatment strategies have significantly reduced mortality for
this group of patients,1 the stage I operation remains one of the most technically chal-
lenging and high-risk surgical procedures in congenital heart disease, as reflected by
its position in the higher categories in either the Risk Adjusted classification for Con-
genital Heart Surgery (RACHS-1) and Aristotle risk adjustment methods.2,3
Until recently, hospital mortality was used as a surrogate for technical performance
in surgery for congenital heart disease. However, there is little available data on the
importance of technical performance in determining outcomes, independent of ana-
tomic factors and postoperative care management. Although risk-adjusted mortality
evaluations allowed a better understanding than general mortality rates, they were
not intended to evaluate individual surgical performance.4 Consequently, we5 have
previously piloted a method to measure technical performance in surgery for congen-
ital heart disease.
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DAbbreviations and Acronyms
BT 5 Blalock–Taussig
ECMO 5 extracorporeal membrane oxygenation
RACHS-1 5 The Risk Adjusted classification for
Congenital Heart Surgery
RV-PA 5 right ventricle–pulmonary artery
The aim of this study is to extend this methodology to the
stage I Norwood procedure and to explore possible correla-
tions between technical performance and clinical outcomes,
as well as means of self-evaluation.
Methods
The Children’s Hospital Boston Internal Review Board approved
this study. A waiver of informed consent was obtained. Patient
data were rendered anonymous in our database in compliance
with the hospital requirements.
Creation of the Measurement Tool
A predischarge technical score was created by dividing the surgical
procedure into individual components defined as ‘‘subprocedures,’’
which are based on the specific anatomic regions subject to interven-
tion. The subprocedures were as follows: atrial septectomy, aortic
root reconstruction (coronary perfusion), proximal aortic arch recon-
struction (distal to sinotubular junction but proximal to innominate
artery), distal aortic arch reconstruction, and source of pulmonary
blood flow (Blalock–Taussig [BT] shunt or right ventricle–pulmo-
nary artery [RV-PA] conduit). For each subprocedure, score cate-
gories were defined as optimal, adequate, and inadequate. The
parameters for score assessment were based on clinical, echocardio-
graphic, and cardiac catheterization data and defined by consensus of
a group of cardiologists and cardiac surgeons at our institution (Ap-
pendix E1). An overall score was also defined, wherein the operation
was graded as optimal if all subprocedures were optimal; adequate if
the subprocedures were optimal or adequate, but none inadequate;
and inadequate if one or more subprocedures were inadequate.
The same subprocedures were also graded at the time of the pre-
Glenn catheterization or magnetic resonance imaging, by creating
definitions for a second ‘‘pre-Glenn’’ technical score. Surviving pa-
tients who had undergone the Glenn procedure at the time of the
study were included. Trends and correlations between the two
scores were explored (Appendix E2).
Data Collection
A retrospective review of all patients undergoing stage I palliation
from January 2004 to December 2006 at Children’s Hospital Boston
was performed. Clinical data (echocardiograms, clinical evaluation,
and catheterization) were collected for assessment. Other variables
collected for analysis included surgeon identification, preoperative
patient characteristics (age and weight at operation, noncardiac
anomalies, anatomic subtype, prematurity, and presence of restric-
tive atrial septum), procedural characteristics (cardiopulmonary by-
pass times and complications, myocardial protection problems, and
bleeding), and postoperative patient characteristics (reinterventions,
length of stay, and in-hospital mortality). Patients who did not have994 The Journal of Thoracic and Cardiovascular Surgery c Octany reliable clinical or echocardiographic information relevant to
the technical score (ie, only available echocardiograms under extra-
corporeal membrane oxygenator [ECMO] support [n5 2] or in-hos-
pital death occurring before any testing [n 5 2] were excluded.
Before they were formally excluded, their records were analyzed
by all coauthor surgeons to ensure that we could not categorize
them on the basis of available clinical data.
Data Analysis
Technical scores were tabulated both overall and for each of the
component subprocedures. Fisher’s exact test was used to explore
the relationships between the technical score and patient character-
istics and outcomes (eg, hospital mortality or surgeon). The
Kruskal–Wallis test was used to explore relationships between tech-
nical outcome and continuous variables (length of stay). Possible
associations between the predischarge score and pre-Glenn scores
were explored by the Wilcoxon signed rank test.
Results
Onehundred fourteen cases of stage I palliationwere identified.
One hundred ten patients were included and 4 were excluded
for lack of reliable postoperative data (Table 1).None of the pa-
tients excludedwere low-risk patients with favorable anatomy.
The procedures were performed by six attending surgeons
who performed 26%, 25%, 19%, 16%, 9%, and 4%, respec-
tively. A complete echocardiogramwas performed at amedian
of 8 days (range1–40days) after the operation. Themedian age
at operationwas 5 days (range 2–42days). Table 2 summarizes
the demographic, anatomic, clinical, and surgical characteris-
tics. Hospital mortality for the study group was 10 (9%) of
110. It is 12% (14/114) if one includes the 4 excluded patients.
The technical performance was graded as optimal in 76 (70%),
adequate in 17 (16%), and inadequate in 15 (14%) of the pa-
tients. Table 3 summarizes subprocedural outcomes. Most of
the scores in every subprocedure were classified as optimal.
The subprocedures with the biggest proportion of inadequate
scoreswere distal arch reconstruction (6%) andBTshunt (5%).
There were few differences in technical performance
based on patient characteristics (Table 4). However, patient
outcomes were different based on the technical score, and
worsened across the three scoring categories. In particular,
inadequate scores markedly increased risk for all clinical out-
comes; risk was nearly 5-fold higher for both in-hospital
death and use of ECMO, and length of stay was nearly twice
as long (Table 5 and Figures 1 and 2).
The pre-Glenn score is presented in Table 6. When com-
pared with the stage I score, a trend toward shifting from the
optimal to the adequate category was noted in every subpro-
cedure. This trend was significant for the RV-PA conduit
(P 5 .0001), for the atrial septectomy (P 5 .01), and for
the modified BT shunt (P5 .05). The distal arch had the big-
gest proportion of inadequate scores (7%).
No statistical differences were found among surgeons
either by subprocedure or by overall outcome, although
individual sample sizes were small.ober 2008
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DDiscussion
Public interest in outcomes for cardiac surgery has signifi-
cantly increased in the past decade. For example, the state
of Massachusetts now requires the mandatory collection of
data by hospitals assessing individual congenital heart sur-
geons’ performance.6 Also, with the current evolution of
health care towards performance-based reimbursements
(‘‘Pay-for-Performance’’, or P4P),7 it becomes imperative
TABLE 1. Patients excluded (n 5 4)
Anatomy Risk factor Data available Outcome Comment
Congenital MS
with moderate
HLV, Noonan
syndrome
Hydrops fetalis No reliable echo data. No
evidence for technical
problems by clinical
observations
Left OR in stable
condition. Died POD 2
(sudden cardiac arrest)
No reliable data re
technical performance
HLHS (AA/MS) On ECMO preop No reliable echo data. No
evidence for technical
problems by clinical
observations. On
ECMO before and after
surgery owing to
pulmonary disease
Unable to wean from CPB
owing to poor
pulmonary function.
In-hospital death (POD
3). Final diagnosis at
autopsy: alveolar
capillary dysplasia
No reliable data re
technical performance
HLHS (AS/MS),
heterotaxy/
polysplenia.
Dysplastic pulmonary
valve with moderate/
severe regurgitation
No reliable echo data Left OR on high-dose
inotropes in critical
condition. In-hospital
death (POD 0)
No reliable data re
technical performance
HLHS (AA/MS),
intact atrial
septum, s/p
emergency
postnatal
atrial stenting
LV–coronary fistulas No echo data.
Transitioned to ECMO
intraop because of low
CO. Signs of posterior
wall ischemia despite
probe- patent proximal
left coronary system
Died POD 1 owing to
diffuse thrombosis of
ECMO circuit. Autopsy
showed signs of early
posterior wall
myocardial infarction
Excluded because
technical coronary
reconstruction
problems vs effect of
LV-dependent coronary
fistulas could not be
demonstrated
MS,Mitral stenosis; HLV, hypoplasic left ventricle; OR, operating room; POD, postoperative day; HLHS, hypoplastic left heart syndrome; AA/MS, aortic atresia
andmitral stenosis; ECMO, extracorporeal membrane oxygenation; CPB, cardiopulmonary bypass; AS/MS, aortic stenosis andmitral stenosis; s/p, status post;
LV, left ventricle; CO, cardiac output.
TABLE 2. Patient and procedure characteristics (n 5 110)
n (%) or median (range)
Age at operation (d) 5 (2-42)
.14 days at operation 6 (5%)
Weight (kg) 3.2 (1.3-4.7)
Weight , 2500 g 17 (15%)
Major noncardiac structural anomaly 4 (4%)
Prematurity 12 (11%)
Female gender 40 (36%)
Length of stay (d) 18 (1-141)
In-hospital mortality 10 (9%)
Intact or restrictive septum 16 (15%)
Morphologic variants
AA/MA 30 (27%)
AA/MS 11 (10%)
AS/MA 4 (4%)
AS/MS 33 (30%)
Others 32 (29%)
CPB times (min) 143 (87-312)
CPB
Crossclamp 61 (0-189)
Circulatory arrest 37 (0-189)
AA/MA, Aortic atresia and mitral atresia; AA/MS, aortic atresia and mitral
stenosis; AS/MA, aortic stenosis and mitral atresia; AS/MS, aortic stenosis
and mitral stenosis; CPB, cardiopulmonary bypass.
TABLE 3. Stage I technical score (n 5 110)
Optimal Adequate Inadequate N/A Total
Overall score 77 (70%) 18 (16%) 15 (14%) 0 110
Subprocedure score
Proximal arch
reconstruction
106 (96%) 0 3 (3%) 1 (1%) 110
Distal arch
reconstruction
88 (80%) 12 (11%) 7 (6%) 3 (3%) 110
Coronary perfusion 107 (97%) 0 1 (1%) 2 (2%) 110
Atrial septectomy 109 (99%) 0 0 1 (1%) 110
Pulmonary blood
source
Modified BT shunt 53 (83%) 6 (9%) 3 (5%) 2 (3%) 64
RV-PA conduit 44 (96%) 1 (2%) 1 (2%) 0 46
N/A (not assessed), No information on this subprocedure on echocardio-
gram; BT, Blalock-Taussig; RV-PA, right ventricle–pulmonary artery.The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 4 995
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Dfor congenital heart surgeons to define optimal or acceptable
surgical performance.8,9 Congenital heart surgeons have very
few, if any, available tools for use for systematic self-assess-
ment as part of an on-going quality improvement evaluation
process. Because technical performance is very difficult to
quantify and measure directly, hospital mortality, usually in
the form of a cumulative sum analysis,10 is often used as a sur-
rogate for measuring performance in heart surgery. While
risk-adjusted in-hospital death rates may be a reasonable
measure of institutional performance, this measure is inade-
quate to assess the performance of individual practitioners,
because many additional factors, outside of the control of
an individual surgeon, may contribute to mortality. This is es-
pecially problematic for single ventricle palliation, which re-
quires a complex multidepartmental team consisting of many
individuals and specialties. We have previously developed
a technical scoring system for common congenital heart pro-
cedures.5 The present study represents a first attempt at defin-
ing and measuring technical performance for the stage I
Norwood operation.
The present stage I score was defined by expert consensus.
This was a difficult undertaking, as there are no prior guide-
lines. We found that the overall outcome was optimal in 70%,
adequate in 16% and inadequate in 14% of the patients. The 3
outcome levels correlated with the mortality rates: 5%, 11%
and 27% respectively (P5 0.02), suggesting a strong impact
of technical performance on hospital survival in stage I pa-
tients. Furthermore, the 5% mortality rate in the ‘‘optimal’’
category also suggests that while excellent technical results
TABLE 4. Technical score depending on patient
characteristics
Optimal
77 (70%)
Adequate
18 (16%)
Inadequate
15 (14%) P value
Weight , 2.5 kg
Yes 12 (71%) 5 (29%) 0 (0%) .09
No 65 (70%) 13 (14%) 15 (16%)
Age . 14 d
Yes 4 (67%) 1 (17%) 1 (17%) .9
No 73 (70%) 17 (16%) 14 (13%)
Hypoplastic left
heart syndrome
Yes 59 (76%) 11 (14%) 8 (10%) .12
No 18 (56%) 7 (22%) 7 (22%)
TABLE 5. Patient outcomes
Optimal Adequate Inadequate P value
Median LOS (range) 18 (2-96) 19 (4-141) 33 (1-125) .02
Hospital mortality (n 5 8) 4 (5%) 2 (11%) 4 (27%) .02
ECMO 6 (8%) 2 (11%) 8 (53%) ,.001
LOS, Length of stay; ECMO, extracorporeal membrane oxygenation.996 The Journal of Thoracic and Cardiovascular Surgery c Octare necessary for survival, they may not be sufficient. A large
role is also likely played by other domains, such as structural
or procedural factors,11 or patient-specific factors (‘‘risk fac-
tors’’).12,13
Because this method allows the identification of the spe-
cific sub-procedures with a bigger proportion of inadequate
outcomes, it may also serve as a method of self-evaluation
or internal quality assurance. This could potentially facilitate
a change in practice and techniques through retraining in the
specific parts of the surgery identified as underperforming.
To avoid concerns regarding the generalization and misun-
derstanding in the interpretation of the data, this method
should be used mostly for self-evaluation and training pur-
poses, until further validation occurs.
The development of the pre-Glenn score was aimed at ex-
ploring the impact of each sub procedure on mid-term ana-
tomic outcomes. A trend towards shifting from optimal to
adequate was noted in every subprocedure, and this was sig-
nificant for the RV-PA conduit and the BT shunt. The distal
arch remained the area with the highest inadequate scores. It
Figure 1. The relationship of Length of stay to technical
performance.
Figure 2. Mortality.ober 2008
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Dis possible that worsening of these anatomic areas was un-
avoidable. However, the pre-Glenn technical scoring system
can have a feed-back function and informs the initial techni-
cal steps of the stage I, thus potentially lowering the number
and morbidity of needed additional procedures at the second
stage.
This study has several limitations. There are many other
important variables for a technically optimal Stage I opera-
tion (i.e. cardiopulmonary bypass management, myocardial
protection, prevention and management of bleeding, avoid-
ance of recurrent laryngeal and phrenic nerve damage, situa-
tional awareness, etc.). We decided not to include them in
the technical score because our intent was to focus on assess-
ing the defined cardiovascular anatomic steps that comprise
the stage I operation. Similarly, important steps that belong
to other health care quality domains such as structure and pro-
cess (i.e. pre-operative care, timely transportation of the pa-
tient to the operating room, anesthesiologists, cardiologists,
nursing and supporting staff, etc) are also not accounted
for. Given the strong correlation between technical score
and outcome however, it is likely that these other factors
play a secondary role in determining early survival and major
complication rate. Although classification of patients that
died as ‘‘optimal’’ or ‘‘adequate’’ may seem counterintuitive,
given our aim to measure the technical outcome specifically,
patient outcomes were not considered. Of note, this approach
allowed us to identify 4 neonates who died despite technically
optimal surgery, highlighting the importance of non-technical
factors, such as those above. Finally, risk-adjustment needs to
be an important part of any performance evaluation to avoid
penalization of surgeons and institutions treating more com-
plex cases.2-4
TABLE 6. Pre-Glenn technical score (n 5 75)
Optimal Adequate Inadequate N/A Total
Overall score 26 (35%) 44 (58%) 5 (7%) 0 75
Subprocedure score
Proximal arch
reconstruction
73 (97%) 2 (3%) 0 0 75
Distal arch
reconstruction
52 (69%) 18 (24%) 5 (7%) 0 75
Coronary perfusion 74 (99%) 0 1 (1%) 0 75
Atrial septectomy 69 (92%) 6 (8%) 0 0 75
Pulmonary blood source
Modified BT shunt 25 (64%) 14 (36%) 0 0 39
RV-PA conduit (Sano) 18 (50%) 18 (50%) 0 0 36
BT, Blalock-Taussig; RV-PA, right ventricle–pulmonary artery.The Journal of ThorAs opposed to our first pilot study,5 this study does not
have the restriction of being based purely on echocardio-
graphy. For example, the difficulties to assess aortic arch
gradients were reduced by including blood pressure and cath-
eterization measurements, which are standard studies avail-
able in the majority of patients. However, some patients
died before any meaningful post-operative study could be
performed. Those patients generally were complicated cases
who were on ECMO either before or immediately after sur-
gery. We are unable to comment on the technical outcome
of these procedures, based on lack of information.
In conclusion, the present score describes a method to
measure technical performance after Stage I surgical pallia-
tion, and is intended to be useful to surgeons for self-evalua-
tion. Avoidance of a technically inadequate outcome was
a major determinant of survival; thus this score should be
an especially useful tool to reduce mortality from this serious
malformation. Future studies will focus on expanding this
methodology to other procedures, prospective validation, as
well as multi-center trials.
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DAPPENDIX E1. Discharge technical score
Subprocedure Optimal Adequate Inadequate
Proximal arch
reconstruction
 No gradient
 No evidence of coronary
ischemia
 Peak velocity , 1.5 m/s
by echo
 Mild gradient at proximal aorto-
pulmonary anastomosis or prox-
imal arch (Dp # 20 mm Hg by
echo or by cath)
 Peak velocity # 2.5 m/s by echo
 Successful intraop revision
 Need for reintervention during
initial hospital stay
 More than mild gradient (Dp.20
mm Hg)
 Peak velocity . 2.5 m/s by echo
 Clinical evidence (symptoms) of
''neo-supra AS''
Distal arch
reconstruction
 No narrowing or flow
acceleration by echo
 No BP gradient
 Peak velocity , 2 m/s
by echo
 Peak velocity # 3 m/s by echo
 Mild gradient (Dp # 20 mm Hg
by echo or by cath)
 Successful intraop revision
 Need for reintervention during
initial hospital stay
 Peak velocity . 3 m/s by echo
 More than mild gradient (Dp .
20 mm Hg)
 Clinical evidence (symptoms) of
coarctation
Coronary
perfusion
 Unobstructed flow into
proximal coronary arteries
 Unobstructed flow into proximal
coronary arteries
 Successful intraop revision
 Need for reintervention during
initial hospital stay Evidence for
obstructed coronary flow
Atrial septectomy  No gradient
 restrictive atrial
septum left on purpose
 Mean gradient # 4 mm Hg  Need for reintervention during
initial hospital stay
 Mean gradient . 4 mm Hg
Source of
pulmonary
blood flow
a. Modified BT shunt  Patent  Patent
 Downsizing of shunt because of
pulmonary overcirculation
 Need for reintervention during
initial hospital stay
 Early symptomatic distortion of
branch PAs
 Symptomatic shunt narrowing
(clot, suture line)
b. RV-PA conduit  Patent  Patent
 Downsizing of shunt because of
pulmonary overcirculation
 Need for reintervention during
initial hospital stay
 Early symptomatic distortion of
branch PAs
 Symptomatic conduit narrowing
(clot, suture line)
BT, Blalock–Taussig; RV-PA, right ventricle–pulmonary artery. Reexploration for bleeding does not count as reintervention (ie, not coded as ''inadequate'').997.e1 The Journal of Thoracic and Cardiovascular Surgery c October 2008
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DAPPENDIX E2. Pre-Glenn score
Subprocedure Optimal Adequate Inadequate
General — —  Unsuitable for BDG
because of anatomic
residua
Proximal arch
reconstruction
 No gradient
 Peak velocity , 1.5 m/s
by echo
 No coronary inflow problem
 Mild gradient at
proximal aortopulmonary anas-
tomosis or proximal
arch (Dp # 20 mm Hg
by cath or BP)
 Peak velocity # 2.5 m/s
by echo
 Need for BD at pre-BDG cath
 More than mild
gradient at proximal
aortopulmonary
anastomosis or
proximal arch
(Dp . 20 mm Hg by
cath or BP)
 Peak velocity . 2.5 m/s
by echo
 Need for surgical plasty
of arch at BDG
Distal arch
reconstruction
 No narrowing or flow
acceleration by echo
 No BP gradient
 Peak velocity , 2 m/s
by echo
 Mild/moderate or
moderate narrowing
or flow acceleration by
cath or BP (Dp # 20 mm Hg)
 Peak velocity # 3 m/s by echo
 Need for BD at pre-BDG cath
 Severe narrowing or
flow acceleration by cath
or BP (Dp . 20 mm Hg)
 Peak velocity . 3 m/s
by echo
 Need for surgical plasty
of arch at BDG
Coronary perfusion  Unobstructed flow into
proximal coronary arteries
 Unobstructed flow into proximal
coronary arteries
 Evidence for obstructed
coronary flow 6 ventricular
dysfunction
Atrial septectomy  No gradient
 Restrictive atrial
septum left on purpose
 Mean gradient # 4 mm Hg
 Need for intervention at BDG
 Mean gradient
. 4 mm Hg
 Evidence for pulmonary
hypertension owing to
restrictive atrial septum
 Need for reintervention
before BDG
Source of pulmonary
blood flow
c. Modified BT shunt  Patent
 Flow into both proximal branch
PAs by echo
 Cath: smooth proximal
and distal anastomosis
 Patent
 Some branch PA distortion at
pre-BDG cath 6 need for BD
 need for reintervention
during interstage (before
the scheduled pre-BDG
cath)
d. RV-PA conduit  Patent
 Flow into both proximal branch
PAs by echo
 cath: smooth proximal
and distal anastomosis
 Patent
 Some branch PA distortion at
pre-BDG cath
 Some proximal narrowing at pre-
BDG cath 6 need for BD
 need for reintervention
during interstage
(not during scheduled
pre-BDG cath)
BD, Balloon dilation; BDG, bidirectional Glenn shunt; PA: pulmonary artery; BT, Blalock–Taussig; RV-PA, right ventricle–pulmonary artery.The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 4 997.e2
